Related Experiment Videos
[Brugada's syndrome]
1Departamento de Electrofisiología Cardiaca, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 México, D. F. mylton@yahoo.com
Archivos De Cardiologia De Mexico
|May 11, 2002
Summary
Brugada syndrome is a heart condition causing sudden death risk. Implantable cardioverter defibrillators are the recommended treatment for this arrhythmic syndrome.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Context:
- Brugada syndrome is a genetic disorder characterized by specific ECG abnormalities.
- It presents with a high risk of sudden cardiac death due to ventricular tachyarrhythmias.
- No structural heart disease is typically found in affected individuals.
Purpose:
- To summarize the key features, prognosis, and treatment of Brugada syndrome.
- To highlight the limitations of antiarrhythmic drugs and the efficacy of implantable cardioverter defibrillators.
Summary:
- Brugada syndrome features ECG changes (right bundle branch block, ST elevation) and carries a significant risk of sudden death.
- Mortality rates can be as high as 10% annually.
- Conventional antiarrhythmic drugs do not improve survival rates.
Impact:
- Definitive treatment involves implantable cardioverter defibrillators (ICDs).
- Early diagnosis and appropriate management are crucial for preventing sudden cardiac death.
- Further research may explore novel therapeutic strategies beyond ICDs.